Study identifies demographic factors associated with long COVID recovery
Yale School of Medicine
May is Asthma and Allergy Awareness Month – the ideal time to get the word out on the different types of asthma, as well as the different triggers and treatments.
Yale School of Medicine immunobiologist Akiko Iwasaki, PhD, will receive the 2024 Nakaakira Tsukahara Memorial Award from the Brain Science Foundation of Japan.
Calling All Experts and Researchers: Share Your Insights on Dengue, Prevention, Detection and Vaccines.
In the wake of the COVID-19 pandemic, many families worried about the long-term effects posed by the SARS-COV-2 virus. Now, researchers found that a SARS-COV-2 infection likely does not increase the risk of asthma development in pediatric patients. The findings were published today in the journal Pediatrics.
Wistar's Dr. Abdel-Mohsen has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV.
A mutation in a protein regulating natural killer (NK) cells’ function is at the root of immune deficiency in some people with a rare genetic condition characterized by cognitive and developmental delay, seizures, and other manifestations. The findings also have broader implications for immunity and cell therapies.
The Federation of American Societies for Experimental Biology (FASEB) bestows its highest honor, FASEB Excellence in Science Awards, to three women scientists.
Researchers with McMaster University have crafted the first-ever guidelines to help prepare families who plan to build their child’s tolerance to common food allergens.
By focusing on a poxvirus protein, a team led by UT Southwestern Medical Center scientists has discovered an antiviral immune pathway that broadly fights a wide variety of viruses. Their findings, reported in Nature Microbiology, could eventually lead to new ways to prevent or treat viral infections or thwart autoimmune diseases.
Wondering why some COVID-19 breakthrough cases feel milder than others? A groundbreaking study led by researchers at the Uniformed Services University (USU) sheds light on this phenomenon, offering insights into post-vaccination immunity dynamics.
Roundup of recent research involving UT Southwestern faculty members: Antibody treatment lowers risk for food allergies; Weight-loss surgery support offered for teens; Racial disparities found among pregnant patients with multiple sclerosis; Gestational age increased at start of COVID-19 pandemic
‘Tis the season of April trickery. Five Penn State health experts help you separate what’s real and what’s myth.
Savage succeeds Bana Jabri, who has chaired the committee since July 2020.
Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases.
Researchers at the Keck School of Medicine, University of Southern California, have discovered that a protein called Piezo1 prevents a type of immune cell in the lung from becoming hyperactivated by allergens.
The American Association of Immunologists today announced the selection of Trainee Members as a Major Symposium speakers for the IMMUNOLOGY2024™ meeting – the premier immunology conference bringing together the best minds, sharing cutting-edge research, and providing opportunities to connect –to be held in Chicago May 3-7, 2024.
The American Association of Immunologists (AAI) is proud to announce the outcome of its recent elections, in which voting members of the association selected the officers and committee leaders who will guide the organization in the years ahead.
Infectious diseases specialists call the medical field to be ready to deal with the impact of climate change on spreading diseases, such as malaria, Valley fever, E-coli and Lyme disease.
Investigators at Cedars-Sinai have identified risk factors that make inflammatory bowel disease (IBD) patients susceptible to developing serious conditions in other parts of their bodies.
Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.
Spring will soon be in bloom, bringing runny and stuffy noses, sneezes and itchy, watery eyes.
Researchers available for interview about their new studies and other women’s health topics
Researchers identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells.
Researchers at the UNC School of Medicine have found that a metabolic enzyme called Acetyl-CoA Carboxylase causes T cells to store fat when they are in solid tumors, rather than burning fat for energy.
Nobel Laureate Brian Kobilka, MD, and NASA Astronaut Jessica Meir, PhD, are among the highlighted speakers who will attend the American Physiology Summit, the American Physiological Society’s (APS) flagship annual meeting.
“We are hoping to use this competition not just as a way to examine the capacity of people to predict vaccination outcomes, but also as a way to address an important public health question,” says Peters.
Recognizing exceptional scientific contributions and noteworthy service to the American Association of Immunologists (AAI) and the wider immunology community, AAI announces its 2024 class of Distinguished Fellows.
A new study highlights a potential therapeutic target for immune-related disorders, such as multiple sclerosis and asthma.
A recently published study that shows lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine.
Nine scientists and physicians in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have been awarded nearly $13 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research and prevention efforts on a wide range of cancer issues. UTSW received another $6 million for recruitment efforts.
Cancer researcher Miguel Reina-Campos, Ph.D., has joined the faculty of La Jolla Institute for Immunology (LJI) as an Assistant Professor to lead the Laboratory of Tissue Immune Networks. His laboratory at LJI aims to investigate the basis of CD8+ T cell tissue immunity to improve life-saving cancer immunotherapies.
Harvard Medical School scientists develop new CRISPR-based tool to study the immune function of genes. New gene-editing approach could optimize how scientists study the immune system’s role in cancer and other immune-mediated diseases.
The eyes have been called the window to the brain. It turns out they also serve as an immunological barrier that protects the organ from pathogens and even tumors, Yale researchers have found.
The biochemist of RUDN University and Institute of Biomedical Chemistry was the first to study how variants of the protein that controls T-lymphocytes affect the development of autoimmune diseases using the example of multiple sclerosis. This will help find new approaches to the treatment of autoimmune diseases.
Bridging precision engineering and precision medicine to create personalized physiology avatars. Pursuing on-demand tissue and organ engineering for human health. Revolutionizing neuroscience by using AI to engineer advanced brain interface systems. Engineering the immune system for health and wellness. Designing and engineering genomes for organism repurposing and genomic perturbations.
A subpopulation of gut bacteria given a commonly used antibiotic became "persisters" that were able to survive without developing true resistance, UT Southwestern Medical Center scientists discovered. Their findings, published in Cell Host & Microbe, could lead to better ways to fight bacterial infections.
As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses
In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer.
The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the Clinical Practice Guideline: Immunotherapy for Inhalant Allergy today in Otolaryngology–Head and Neck Surgery.
A study led by Johns Hopkins Children’s Center shows omalizumab — an injectable, Food and Drug Administration (FDA)-approved medication for treating asthma and other allergic conditions — substantially reduced potentially life-threatening reactions in patients with an allergy to peanut and other common food allergies.
Scientists at the University of Southampton have discovered that bacteria can pair up their defense systems to create a formidable force, greater than the sum of its parts, to fight off attack from phage viruses.